Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
40000 participants
OBSERVATIONAL
2009-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Registry for Proton Beam Radiation Therapy
NCT02040467
Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
NCT00750269
Stereotactic Radiotherapy (SBRT) of Lung Metastasis
NCT01803542
Proton Radiation Therapy Registry
NCT04376229
Proton Radiotherapy for Recurrent Tumors
NCT01126476
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment with Radiation Therapy
Includes 16 different arms to capture patient data by disease site
Proton Therapy, Photon Therapy, SRS, Brachytherapy
Outcomes Tracking
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Proton Therapy, Photon Therapy, SRS, Brachytherapy
Outcomes Tracking
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to understand and sign IRB approved consent
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Proton Collaborative Group
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carlos Vargas, MD
Role: STUDY_CHAIR
Proton Collaborative Group
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic
Scottsdale, Arizona, United States
Proton Center of Arkansas
Little Rock, Arkansas, United States
California Protons Cancer Therapy Center
San Diego, California, United States
South Florida Proton Therapy Institute
Delray Beach, Florida, United States
Ackerman Cancer Center
Jacksonville, Florida, United States
Dwoskin Proton Therapy Center
Miami, Florida, United States
Miami Cancer Institute
Miami, Florida, United States
Orlando Health Cancer Institute
Orlando, Florida, United States
Emory Proton Therapy Center
Atlanta, Georgia, United States
OSF HealthCare Cancer Institute
Peoria, Illinois, United States
Northwestern Medicine Chicago Proton Center
Warrenville, Illinois, United States
University of Kansas Proton Therapy Center
Kansas City, Kansas, United States
Kansas City Proton Institute
Overland Park, Kansas, United States
Willis-Knighton Cancer and Proton Therapy Center
Shreveport, Louisiana, United States
Maryland Proton Treatment Center
Baltimore, Maryland, United States
McLaren Proton Therapy Center
Flint, Michigan, United States
Washington University in St. Louis
St Louis, Missouri, United States
Mercy David C. Pratt Cancer Center
St Louis, Missouri, United States
ProCure Proton Therapy Center
Somerset, New Jersey, United States
New York Proton Center
New York, New York, United States
Atrium Health Levine Cancer Proton & Advanced Radiation Center
Charlotte, North Carolina, United States
University of Cincinnati Medical Center
Cincinnati, Ohio, United States
Oklahoma Proton Center
Oklahoma City, Oklahoma, United States
Tennessee Oncology Proton Center
Franklin, Tennessee, United States
Thompson Proton Center
Knoxville, Tennessee, United States
Texas Center for Proton Therapy
Irving, Texas, United States
Inova Schar Cancer Institute
Fairfax, Virginia, United States
Hampton University Proton Therapy Institute
Hampton, Virginia, United States
University of Washington
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Clinical Trials Office - All Mayo Clinic Locations
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Lee HJ Jr, Macomber MW, Spraker MB, Bowen SR, Hippe DS, Fung A, Russell KJ, Laramore GE, Rengan R, Liao J, Apisarnthanarax S, Zeng J. Early toxicity and patient reported quality-of-life in patients receiving proton therapy for localized prostate cancer: a single institutional review of prospectively recorded outcomes. Radiat Oncol. 2018 Sep 17;13(1):179. doi: 10.1186/s13014-018-1127-6.
Related Links
Access external resources that provide additional context or updates about the study.
Sponsor's website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REG001-09
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.